FIELD: chemistry.
SUBSTANCE: invention refers to compounds of formula (I).
(I).
EFFECT: technical result is obtaining novel compounds suitable as PDE1 inhibitors which can be used as a medicament, particularly for treating neurodegenerative disorders and psychiatric disorders.
15 cl, 1 tbl, 100 ex
| Title |
Year |
Author |
Number |
| 8-METHYL-1-PHENYLIMIDAZO[1,5-a]PYRAZINE COMPOUNDS |
2011 |
- Man De Adrianus Petrus Antonius
- Revinkel Jokhannes Bernardus Marija
- Jans Khristian Gerardus Jokhannes Marija
- Rajmakers Khans Kornelis Andreas
- Vejkmans Jakobus Kornelis Khenrikus Marija
|
RU2560162C2 |
| NEW IMIDAZO[4,5-c]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS |
2018 |
- Brodney Michael Aaron
- Chappie Thomas Allen
- Chen Jinshan Michael
- Coe Jotham Wadsworth
- Coffman Karen Jean
- Galatsis Paul
- Garnsey Michelle Renee
- Helal Christopher John
- Henderson Jaclyn Louise
- Kormos Bethany Lyn
- Kurumbail Ravi G.
- Martinez-Alsina Luis Angel
- Pettersson Martin Youngjin
- Reese Matthew Richard
- Rose Colin Richard
- Stepan Antonia Friederike
- Verhoest Patrick Robert
- Wager Travis T.
- Warmus Joseph Scott
- Zhang Yuan
|
RU2773516C2 |
| IMIDAZOPYRAZINES |
2012 |
- Lyuk Kin-Chun Tomas
- Sot Majkl
|
RU2600327C2 |
| PYRAZINE COMPOUNDS AND THEIR USE |
2019 |
- Qi Changhe
- Tsui Honchung
- Zeng Qingbei
- Yang Zhenfan
- Zhang Xiaolin
|
RU2809631C2 |
| HETEROARYL COMPOUNDS, COMPOSITIONS CONTAINING THEM AND METHODS OF TREATING WITH USE OF SUCH COMPOUNDS |
2007 |
- Mortensen Debora S'Ju
- Mederos Marija Mersedes Del'Gado
- Sapienza Dzhon Dzhozef
- Al'Bers Ronald Dzh.
- Li Brehnden G.
- Kharris Roj Leonard Iii
- Shevlin Graziehlla Izabel
- Khuan Dekhua
- Shvarts Kimberli Lin
- Pakard Garrik K.
- Parns Dzhejson Sajmon
- Papa Patrik Uill'Jam
- Terani Lida Radnija
- Perren-Ninkovich Sofi
- Riggz Dzhennifer R.
|
RU2478635C2 |
| PYRAZOLO [3,4-C] PYRIDINES AND METHODS OF APPLICATION THEREOF |
2012 |
- Do Stiven
- Khu Khuejyun
- Kolesnikov Aleksandr
- Li Vendi
- Tsui Viki Khsyao-Vej
- Van Syaotszin
- Ven Chzhaoyan
|
RU2638116C2 |
| NEW DERIVATIVES OF IMIDAZO [4,5-C] QUINOLINES AND IMIDAZO [4,5-C] [1,5] NAPHTHYRIDINES AS LRRK2 INHIBITORS |
2016 |
- Galatsis Paul
- Henderson Jaclyn Louise
- Kormos Bethany Lyn
- Kurumbail Ravi G.
- Reese Matthew Richard
- Stepan Antonia Friederike
- Verhoest Patrick Robert
- Wager Travis T.
- Pettersson Martin Youngjin
- Garnsey Michelle Renee
|
RU2722149C1 |
| HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS |
2018 |
- Vadivelu, Saravanan
- Rajagopal, Sridharan
- Burri, Raghunadha Reddy
- Garapaty, Shivani
- Sivanandhan, Dhanalakshmi
- Thakur, Manish Kumar
- Natarajan, Tamizharasan
- Swamy, Indu N
- Nagaraju, Nagendra
- Kanagaraj, Subramaniam
- Mohd, Zainuddin
- Sarkar, Sayantani
- Samanta, Swapan Kumar
- Hariprakash
|
RU2797822C2 |
| IMIDAZOPYRIDINE COMPOUNDS AS PAD INHIBITORS |
2018 |
- Hallur Gurulingappa
- Duraiswamy Athisayamani Jeyaraj
- Purra Buchi Reddy
- Rao N.V.S.K.
- Rajagopal Sridharan
- Kristam Rajendra
|
RU2782743C2 |
| PHENOXYPYRIDINYLAMIDE DERIVATIVES, AND THEIR USE IN TREATMENT OF PDE4-MEDIATED DISEASE STATES |
2009 |
- Ehndrjus Glen
- Koks Rona Dzhejn
- De Savi Kristofer
- Megani Premdzhi
- Sangani Khitesh Dzhajantilal
- Uorner Daniehl' Dzhon
|
RU2509077C2 |
